ATE532416T1 - Fermentierte milchproteine mit rezeptor-ligand und ihre verwendungen - Google Patents

Fermentierte milchproteine mit rezeptor-ligand und ihre verwendungen

Info

Publication number
ATE532416T1
ATE532416T1 AT05784554T AT05784554T ATE532416T1 AT E532416 T1 ATE532416 T1 AT E532416T1 AT 05784554 T AT05784554 T AT 05784554T AT 05784554 T AT05784554 T AT 05784554T AT E532416 T1 ATE532416 T1 AT E532416T1
Authority
AT
Austria
Prior art keywords
receptor ligand
fermented milk
milk proteins
mammal
relief
Prior art date
Application number
AT05784554T
Other languages
English (en)
Inventor
Benedicte Flambard
Original Assignee
Chr Hansen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chr Hansen As filed Critical Chr Hansen As
Application granted granted Critical
Publication of ATE532416T1 publication Critical patent/ATE532416T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Developmental Biology & Embryology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
AT05784554T 2004-09-03 2005-09-05 Fermentierte milchproteine mit rezeptor-ligand und ihre verwendungen ATE532416T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200401339 2004-09-03
PCT/EP2005/054363 WO2006024673A1 (en) 2004-09-03 2005-09-05 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof

Publications (1)

Publication Number Publication Date
ATE532416T1 true ATE532416T1 (de) 2011-11-15

Family

ID=35344722

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05784554T ATE532416T1 (de) 2004-09-03 2005-09-05 Fermentierte milchproteine mit rezeptor-ligand und ihre verwendungen

Country Status (12)

Country Link
US (2) US7883697B1 (de)
EP (1) EP1796480B1 (de)
JP (1) JP2008511593A (de)
CN (1) CN101035433B (de)
AT (1) ATE532416T1 (de)
AU (1) AU2005279163B2 (de)
BR (1) BRPI0514903A (de)
CA (1) CA2577613C (de)
DK (1) DK1796480T3 (de)
NZ (1) NZ554278A (de)
RU (1) RU2403051C2 (de)
WO (1) WO2006024673A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ554278A (en) * 2004-09-03 2009-11-27 Chr Hansen As Fermented milk or vegetable proteins comprising receoptor ligand and uses thereof
JP2009046456A (ja) * 2007-08-23 2009-03-05 Kikkoman Corp 生殖行動の誘発用組成物
NZ606767A (en) 2010-07-15 2015-08-28 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
GB2495885B (en) * 2010-07-15 2017-11-22 Iliich Epshtein Oleg Combination pharmaceutical composition and methods of treating genitourinary system disorders
ITPI20110033A1 (it) * 2011-04-01 2012-10-02 Funcional Food Res S R L Preparazione alimentare funzionale ad uso maschile.
FI126711B (fi) * 2011-10-12 2017-04-13 Gut Guide Oy Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
WO2016182053A1 (ja) 2015-05-13 2016-11-17 アサヒカルピスウェルネス株式会社 運動時の心拍数上昇抑制方法及び心拍数上昇抑制組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436264A (en) * 1993-08-19 1995-07-25 Syntex (U.S.A.) Inc. N-aryloxyalkyl tryptamine α1 -adrenergic receptor antagonists
US5637617A (en) * 1994-04-01 1997-06-10 The Regents Of The University Of California Methods for use of GABAa receptor GABAergic compounds
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
WO1998043498A1 (fr) * 1997-04-01 1998-10-08 Nichimo Co., Ltd. Produit comprenant un ingredient favorable a la sante et son procede de production
US5854029A (en) 1996-08-02 1998-12-29 Calpis Co., Ltd. Method for preparing antihypertensive agent
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤
JP3028411B2 (ja) 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
FI113741B (fi) 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
NZ523036A (en) 2000-05-08 2004-04-30 Davisco Foods Internat Inc Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals
US20020182274A1 (en) * 2001-03-21 2002-12-05 Kung-Ming Lu Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
AU2003214038A1 (en) * 2002-04-03 2003-10-13 Chr. Hansen A/S Peptides with anti-hypertensive properties
US20040077624A1 (en) * 2002-05-23 2004-04-22 Pfizer Inc. Novel combination
CN100451127C (zh) 2002-08-09 2009-01-14 科·汉森有限公司 制备具有抗高血压特性的肽的方法
NZ554278A (en) * 2004-09-03 2009-11-27 Chr Hansen As Fermented milk or vegetable proteins comprising receoptor ligand and uses thereof

Also Published As

Publication number Publication date
US20110195891A1 (en) 2011-08-11
WO2006024673A1 (en) 2006-03-09
EP1796480A1 (de) 2007-06-20
US7883697B1 (en) 2011-02-08
CA2577613A1 (en) 2006-03-09
NZ554278A (en) 2009-11-27
AU2005279163A1 (en) 2006-03-09
RU2403051C2 (ru) 2010-11-10
CA2577613C (en) 2015-12-15
BRPI0514903A (pt) 2008-06-24
DK1796480T3 (da) 2012-02-13
CN101035433A (zh) 2007-09-12
RU2007112116A (ru) 2008-10-10
CN101035433B (zh) 2011-09-07
EP1796480B1 (de) 2011-11-09
US8367604B2 (en) 2013-02-05
JP2008511593A (ja) 2008-04-17
AU2005279163B2 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
ATE532416T1 (de) Fermentierte milchproteine mit rezeptor-ligand und ihre verwendungen
EA201071136A1 (ru) Способ получения стабильного натурального красителя, продукты и их применение
EP2179666A3 (de) Rauchlose Tabakzusammensetzungen und Verfahren zur Behandlung von Tabak zu dessen Verwendung darin
TW200628078A (en) Method for enhancing acrylamide decompsistion
NO20071641L (no) Vevs-konstruert kjott for konsum og en fremgangsmate for fremstilling av vevs-konstruert kjott for konsum
BRPI0811104A2 (pt) Método para produzir um alimento de carne processado ou um alimento de pesca processado, e, preparação de enzima para modificar um alimento de carne processado ou alimento de pesca preocessado
NO20051993L (no) Framgangsmate og fôr for reduksjon av innholdet av uonskede naeringsstoffer i avlopsvann fra fiskeoppdrettsanlegg
WO2012002714A3 (ko) 폴리페놀과 에스-알릴시스테인이 강화된 흑마늘 및 그 제조방법
FI20070944A0 (fi) Uusi syötävä koostumus
CN104430163A (zh) 一种黑天鹅的饲养方法
WO2010058198A3 (en) Antimicrobial material
GB201116841D0 (en) Methods of ensiling algae, ensiled algae and uses of ensiled algae
WO2008046993A3 (fr) Nouveau produit biologique d'origine marine, son procede d'obtention et ses utilisations
MX2015007884A (es) Composicion de alimento para animales y proceso para produccion.
CN105541456A (zh) 一种有助于促进辣椒光合作用提高产量的高效肥料及其制备方法
CA2657756C (en) Dry food to reduce dogs' appetites
CN201683573U (zh) 一种新型碗
GEU20071362Y (en) Method for production of biologically active foodstuff
RU2541650C1 (ru) Способ приготовления кормовой добавки из каныги для откорма рыб
CN102559451A (zh) 鲜鹿血酒制作方法
UA104582C2 (ru) Стабильная в хранении, жидкая кулинарная основа без консервантов, способ ее приготовления и пищевая композиция, содержащая ее
CN106915982A (zh) 一种香菇菌棒及其制备方法
CN104170752A (zh) 一种肥猪绿色生态养殖方法
Johnston et al. Improving pig welfare–the role of dietary fiber
KR20100115331A (ko) 마늘젓갈분말